Tag: Biopharma

biospace
United States

Artificial Intelligence in Diagnostics Market Size to Hit USD 8.54 Bn by 2033

Press Release – December 3, 2024 According to Precedence Research, the global artificial intelligence in diagnostics market size was exhibited at USD 1.61 billion in 2024 and is projected to hit around USD 8.54 billion by 2033, growing at a CAGR of 20.37% during the forecast period 2024 to 2033. Artificial Intelligence in Diagnostics Market Key Takeaways •  North America dominated the market with a revenue share … Continue reading Artificial Intelligence in Diagnostics Market Size to Hit USD 8.54 Bn by 2033

Impact Newswire
axolbio
Europe

Axol Bioscience acquires Phenocell to advance human disease models

Acquisition expands Axol’s iPSC-derived cell models and service offering to include ophthalmology and dermatology CAMBRIDGE / EDINBURGH, UK, and GRASSE, FRANCE, October 2024: Axol Bioscience Ltd. (Axol), a leading induced pluripotent stem cell (iPSC) technology provider for drug discovery, today announced it has fully acquired Phenocell SAS, a pioneer in iPSC-based products and bioassays for skin and retinal disorders. The acquisition extends Axol’s portfolio of iPSC-derived cell … Continue reading Axol Bioscience acquires Phenocell to advance human disease models

Impact Newswire
United States

BPGbio Appoints Esteemed Cancer Researcher Dr. Dipanjan Chowdhury to Scientific Advisory Board

Appointment Enhances Leadership in Protein Homeostasis and Oncology Translational Medicine BOSTON – BPGbio, Inc., a leading biology-first, AI-powered, clinical stage biopharma focused on mitochondrial biology and protein homeostasis, today announced the addition of Dr. Dipanjan Chowdhury, a distinguished cancer researcher, to its Advisory Board. With his extensive expertise in early translational research and a deep understanding of aggressive solid tumors, Dr. Chowdhury will provide valuable guidance to enhance … Continue reading BPGbio Appoints Esteemed Cancer Researcher Dr. Dipanjan Chowdhury to Scientific Advisory Board

Impact Newswire